Document is current
Any future updates will be listed below
-
Authors
Konigsberg, Iain R.
Lin, Nancy W.
Liao, Shu-Yi
Liu, Cuining
MacPhail, Kristyn
Mroz, Margaret M.
Davidson, Elizabeth
Restrepo, Clara I.
Sharma, Sunita
Li, Li
Maier, Lisa A.
Yang, Ivana V.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR001082)
Foundation for Sarcoidosis Research (22-505-RFP)
National Heart, Lung, and Blood Institute (R01HL140357)
National Institute of Environmental Health Sciences,United States (R01ES023826, R01ES023826)
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 18 July 2024
First Online: 30 July 2024
Declarations
:
: All subjects provided written informed consent to participate in this study. The study was approved by the NJH Institutional Review Board (HS-3159-528).
: Not applicable.
: L.A.M. has received grant support from the Foundation for Sarcoidosis and Mallinckrodt Pharmaceuticals and serves on the advisory board for the Foundation for Sarcoidosis and the sarcoidosis advisory board for Boehringer Ingelheim. I.V.Y. has received financial support to attend the 2023 World Association for Sarcoidosis and Other Granulomatous Disorders conference and consulting fees from ElevenP15 unrelated to this work. The remaining authors do not have conflicts of interest relating to this work to disclose.
